|

5-FU, leucovorin, docetaxel, oxaliplatin (FLOT) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Yu jiren1

Indications

  • Adenocarcinoma of Esophagogastric Junction1
  • Adenocarcinoma of the Stomach1
  • HER2-positive Gastric Cancer1
  • Cancer1

Other1 trial

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.